Drug Profile
Hepatitis B vaccine - GenPhar
Latest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator GenPhar
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 21 Mar 2007 GenPhar's Hepatitis B vaccine is available for licensing (www.genphar.com)
- 21 Mar 2007 Phase-I clinical trials in Hepatitis B in USA (Parenteral)
- 18 Apr 2002 Preclinical trials in Hepatitis B in USA (Parenteral)